Academia
The new LaunchLabs incubator program is expected to open in 2020. This is the second incubator program Columbia University has become involved with this month.
Almost 15,000 physicians, scientists, health care professionals and industry representatives from around the globe presented research, treatment recommendations and advances toward a diabetes cure at the American Diabetes Association’s 79th Scientific Sessions in San Francisco this week.
An article published in Experimental Biology and Medicine details a new therapeutic strategy for obesity and type 2 diabetes.
Here’s a look at some of last week’s clinical trial announcements, including some from the American Society of Clinical Oncology Annual Meeting you might have missed.
Phase II data showed the triple combination treatment provided 16 months of progression-free survival of patients.
Here are some of the top research stories that happened around the industry this week.
Globally, TB is the leading cause of death by an infectious disease. It is caused by a bacterium, Mycobacterium tuberculosis.
The researchers, in analyzing more than 400,000 genomes and associated health records, found that individuals with two mutated copies of the CCR5 gene, the one He Jiankui modified, had a significantly higher death rate between the ages 41 and 78 than people with one or no copies.
As a valued member of our BioSpace community, we are eager to hear more from you and other readers in 2019. We want to know your if you have ‘work-life balance’ with your job.
Nearly half the amplitude typically used in standard electroconvulsive therapy (ECT) seems to be effective at treating suicidal thoughts, investigators report.
PRESS RELEASES